These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 9850036)

  • 1. Economic issues in lung cancer: a review.
    Goodwin PJ; Shepherd FA
    J Clin Oncol; 1998 Dec; 16(12):3900-12. PubMed ID: 9850036
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost of combined modality interventions for stage III non-small-cell lung cancer.
    Evans WK; Will BP; Berthelot JM; Earle CC
    J Clin Oncol; 1997 Sep; 15(9):3038-48. PubMed ID: 9294466
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic and therapeutic approaches to lung cancer in Canada and their costs.
    Evans WK; Will BP; Berthelot JM; Wolfson MC
    Br J Cancer; 1995 Nov; 72(5):1270-7. PubMed ID: 7577481
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estimating the cost of lung cancer diagnosis and treatment in Canada: the POHEM model.
    Evans WK; Will BP; Berthelot JM; Wolfson MC
    Can J Oncol; 1995 Dec; 5(4):408-19. PubMed ID: 8770457
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The economics of lung cancer management in Canada.
    Evans WK; Will BP; Berthelot JM; Wolfson MC
    Lung Cancer; 1996 Feb; 14(1):19-29. PubMed ID: 8696718
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Economic analysis of the TAX 317 trial: docetaxel versus best supportive care as second-line therapy of advanced non-small-cell lung cancer.
    Leighl NB; Shepherd FA; Kwong R; Burkes RL; Feld R; Goodwin PJ
    J Clin Oncol; 2002 Mar; 20(5):1344-52. PubMed ID: 11870178
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost-effectiveness of Lung Cancer Screening in Canada.
    Goffin JR; Flanagan WM; Miller AB; Fitzgerald NR; Memon S; Wolfson MC; Evans WK
    JAMA Oncol; 2015 Sep; 1(6):807-13. PubMed ID: 26226181
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Economic issues in lung cancer.
    Bordeleau L; Goodwin PJ
    Semin Respir Crit Care Med; 2000; 21(5):375-84. PubMed ID: 16088749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The cost of managing lung cancer in Canada.
    Evans WK; Will BP; Berthelot JM; Wolfson MC
    Oncology (Williston Park); 1995 Nov; 9(11 Suppl):147-53. PubMed ID: 8608046
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The economic burden of lung cancer and the associated costs of treatment failure in the United States.
    Kutikova L; Bowman L; Chang S; Long SR; Obasaju C; Crown WH
    Lung Cancer; 2005 Nov; 50(2):143-54. PubMed ID: 16112249
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The financial impact of smoking on health-related costs: a review of the literature.
    Max W
    Am J Health Promot; 2001; 15(5):321-31. PubMed ID: 11502013
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The long-term cost-effectiveness of varenicline (12-week standard course and 12 + 12-week extended course) vs. other smoking cessation strategies in Canada.
    von Wartburg M; Raymond V; Paradis PE
    Int J Clin Pract; 2014 May; 68(5):639-46. PubMed ID: 24472120
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lifetime costs of colon and rectal cancer management in Canada.
    Maroun J; Ng E; Berthelot JM; Le Petit C; Dahrouge S; Flanagan WM; Walker H; Evans WK
    Chronic Dis Can; 2003; 24(4):91-101. PubMed ID: 14733758
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The economic and social costs of lung cancer and the economics of smoking prevention.
    Godfrey C
    Monaldi Arch Chest Dis; 2001 Oct; 56(5):458-61. PubMed ID: 11887505
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Counting the costs of chemotherapy in a National Cancer Institute of Canada randomized trial in nonsmall-cell lung cancer.
    Jaakkimainen L; Goodwin PJ; Pater J; Warde P; Murray N; Rapp E
    J Clin Oncol; 1990 Aug; 8(8):1301-9. PubMed ID: 2166142
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost of treating patients with smoking history in a specialized cancer hospital.
    Pinto M; Ugá MA
    Rev Saude Publica; 2011 Jun; 45(3):575-82. PubMed ID: 21519723
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of skeletal complications on total medical care costs among patients with bone metastases of lung cancer.
    Delea TE; McKiernan J; Brandman J; Edelsberg J; Sung J; Raut M; Oster G
    J Thorac Oncol; 2006 Jul; 1(6):571-6. PubMed ID: 17409919
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost-utility analysis of short- versus long-course palliative radiotherapy in patients with non-small-cell lung cancer.
    van den Hout WB; Kramer GW; Noordijk EM; Leer JW
    J Natl Cancer Inst; 2006 Dec; 98(24):1786-94. PubMed ID: 17179480
    [TBL] [Abstract][Full Text] [Related]  

  • 19. First data on direct costs of lung cancer management in Morocco.
    Tachfouti N; Belkacemi Y; Raherison C; Bekkali R; Benider A; Nejjari C
    Asian Pac J Cancer Prev; 2012; 13(4):1547-51. PubMed ID: 22799364
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost-effectiveness analysis of varenicline versus existing smoking cessation strategies in Central America and the Caribbean using the BENESCO model.
    Lutz MA; Lovato P; Cuesta G
    Hosp Pract (1995); 2012 Feb; 40(1):24-34. PubMed ID: 22406880
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.